Cargando…
Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Amyloid-related imaging abnormalities (ARIA) represent the major severe side effect of amyloid-beta (Aβ) immunotherapy for Alzheimer’s disease (AD). Early biomarkers of ARIA represent an important challenge to ensure safe and beneficial effects of immunotherapies, given that different promising clin...
Autores principales: | DiFrancesco, Jacopo C., Longoni, Martina, Piazza, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585101/ https://www.ncbi.nlm.nih.gov/pubmed/26441825 http://dx.doi.org/10.3389/fneur.2015.00207 |
Ejemplares similares
-
Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study
por: Antolini, Laura, et al.
Publicado: (2021) -
Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
por: Weller, Roy O, et al.
Publicado: (2009) -
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management
por: Crosta, Francesca, et al.
Publicado: (2015) -
Immunotherapy with ponezumab for probable cerebral amyloid angiopathy
por: Leurent, Claire, et al.
Publicado: (2019) -
Gait in Cerebral Amyloid Angiopathy
por: Sharma, Breni, et al.
Publicado: (2022)